Shingou Miyamoto - Gynecology

Author Information

Dr. Shingo Miyamoto is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at the Faculty of Medicine, Fukuoka University, located in Fukuoka, Japan. His prolific contributions to the field highlight his active engagement in advancing gynecological research and practice.

Research Contributions

Dr. Miyamoto's research spans multiple facets of gynecology and related biomedical fields. His recent works include exploring biomarkers for chorioamnionitis and the microbiota communities in infertile women with a history of repeated implantation failure. His study on predicting high-risk births using convolutional neural networks showcases his innovative approach to integrating technology with medical research. Furthermore, he has delved into cancer research, examining factors like NRAS- or HRAS-mutated non-small cell lung cancer and the medical costs associated with lung cancer care in Japan. His interdisciplinary research efforts underscore a commitment to improving both diagnostic and therapeutic methods in gynecology and oncology.

Aliases

Dr. Shingo Miyamoto is known by several aliases, including S Miyamoto, S. Miyamoto, Shingo Miyamoto, and Shingou Miyamoto. These variations are often seen across different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	4935
H-Index	39
Paper Count	280

Publications:

Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells

DOI: 10.3164/jcbn.21-74

Year: 2022

Preoperative Magnetic Resonance Imaging versus Intraoperative Frozen Section Diagnosis for Predicting the Deep Myometrial Invasion in Endometrial Cancer: Our Experience and Literature Review

DOI: 10.1111/jog.14891

Year: 2021

Predicting high risk birth from real large-scale cardiotocographic data using multi-input convolutional neural networks

DOI: 10.1587/nolta.12.399

Year: 2021

Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failure

DOI: 10.1002/rmb2.12389

Year: 2021

MicroRNAs miR-4535 and miR-1915-5p in amniotic fluid as predictive biomarkers for chorioamnionitis

DOI: 10.2144/fsoa-2021-0006

Year: 2021

Diagnostic predictability of miR-4535 and miR-1915-5p expression in amniotic fluid for foetal morbidity of infection.

DOI: 10.1016/j.placenta.2021.08.059

Year: 2021

Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.

DOI: 10.1093/jjco/hyaa258

Year: 2021

Clinico-pathological and genomic features of NRAS- or HRAS-mutated non-small cell lung cancer (NSCLC) identified in large-scale genomic screening project (LC-SCRUM-Asia).

DOI: 10.1200/JCO.2021.39.15_SUPPL.9054

Year: 2021

Peri-operative complications of Total laparoscopic hysterectomy for benign gynecological diseases in Fukuoka university

DOI: 10.5180/JSGOE.37.1_7

Year: 2021

Significant Antitumor Activity of Pazopanib in a Patient with PDGFRB-Mutated Metastatic Phyllodes Tumor: a Case Report

DOI: 10.1007/s42399-021-00796-5

Year: 2021

What is the Role of Vaccinations in Gynecology?

What Hormonal Factors Influence Muscle Mass in Women?

What Is the Economic Impact of Gynecological Research?

How to Prepare for Gynecological Tests?

How Does ORCID Benefit Gynecologists?

How is SAH Diagnosed in Pregnant Women?

Why is Patient Confidentiality Important?

What Factors Influence Dosage Control?

Why is IBS Relevant in Gynecology?

Who Should Get a Vaginal Smear?

Partnered Content Networks

Relevant Topics